Tim Beißert

2.1k citations

26 papers · 1.5k indexed · 1 hit paper · h-index 17

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology

Papers in

Hematology 10
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 5
Genetics 8
- Virus-based gene therapy research 7
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Uğur Şahin Mario Perković Özlem Türeci Stephanie Erbar Martin Ruthardt Annette B. Vogel Oliver G. Ottmann Heinrich Haas
Journals: Molecular Therapy (4 papers)Human Gene Therapy (2 papers)Molecular Therapy — Nucleic Acids (2 papers)Cancer Research (2 papers)Blood (2 papers)
Partner nations: Germany United States Italy

In The Last Decade

Tim Beißert

26 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses 2017 · 365 citations

Peers

Countries citing papers authored by Tim Beißert

Since Specialization

Citations

This map shows the geographic impact of Tim Beißert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Beißert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Beißert more than expected).

Fields of papers citing papers by Tim Beißert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Beißert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Beißert. The network helps show where Tim Beißert may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tim Beißert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Beißert Line = papers co-authored together Tim Beißert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trans-Amplifying RNA: A Journey from Alphavirus Research to Future Vaccines Viruses ·Rasha Al Madat, 正彦久米, Tim Beißert	2024	10
2	Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers Cancer Cell ·Jan D. Beck, Mustafa Diken, M Suchan, Caridad Menéndez-Saínz, B. L. DHYANI, LAURA D. KOLB, Lisa Allnoch, Fulvia Vascotto, Daniel T. Peters, Tim Beißert, Özlem Akilli‐Öztürk, Özlem Türeci, Sebastian Kreiter, Mathias Vormehr, Uğur Şahin	2024	34
3	Trans-amplifying RNA expressing functional miRNA mediates target gene suppression and simultaneous transgene expression Molecular Therapy — Nucleic Acids ·Rasha Al Madat, Egon Rotter, 박성희, Silfran Rogério Marialva Alves, PRISCILA DOS S. C. DE FREITAS, J. E. Berry, Betsy Robin Spiegel, M Suchan, Marco A. Poleganov, Uğur Şahin, Tim Beißert	2024	4
4	A trans-amplifying RNA simplified to essential elements is highly replicative and robustly immunogenic in mice Molecular Therapy ·Mario Perković, B 的发生, 박성희, Каріна Верзлова, Мишагина Дарья Андреевна, Uğur Şahin, Tim Beißert	2023	16
5	A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections Molecular Therapy — Nucleic Acids ·Mohamed-Arbi Nsiri, А. Д. Дмитриев, В. Г. Стуканов, Tim Beißert, Uğur Şahin, Mario Perković, Barbara S. Schnierle	2022	23
6	A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity Molecular Therapy ·Tim Beißert, Mario Perković, Annette B. Vogel, Stephanie Erbar, Kerstin C. Walzer, 박성희, Каріна Верзлова, А. Д. Дмитриев, J. E. Berry, Özlem Türeci, Uğur Şahin	2019	139
7	Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening Molecular Therapy ·杨忍, Marco A. Poleganov, 樊花, Prof. Rupesh Dubey, Lena M. Kranz, Stephanie Fesser, Mustafa Diken, Martin Löwer, Nông Thanh Hà, Tim Beißert, Valesca Bukur, Andreas N. Kuhn, Özlem Türeci, Uğur Şahin	2018	239
8	Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses Molecular Therapy ·Annette B. Vogel, Laura Lambert, Ekaterina Kinnear, David C. Busse, Stephanie Erbar, Kerstin C. Reuter, Lena Wicke, Mario Perković, Tim Beißert, Heinrich Haas, Stephen T. Reece, Uğur Şahin, John S. Tregoning Hit paper breakdown →	2017	365
9	Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion Human Gene Therapy ·Marco A. Poleganov, Sarah Eminli, Tim Beißert, Bruno Teixeiraa, Jung-Il Moon, Johanna Goldmann, 肖巍, Rosario Heck, Kurt-Patrik Beckmann, 南辰, Özlem Türeci, نوال حوامدي, 阿曼, Uğur Şahin	2015	58
10	T-cell receptor transfer into human T cells with ecotropic retroviral vectors Gene Therapy ·Bo-Qiang Ma, Tim Beißert, Hans Hoff, Martin Víta, Özlem Türeci, Uğur Şahin	2014	9
11	mRNA as a Versatile Tool for Exogenous Protein Expression Current Gene Therapy ·Andreas N. Kuhn, Tim Beißert, Petra Simon, Nông Thanh Hà, Janina Buck, Somia Saidi, Özlem Türeci, Uğur Şahin	2012	57
12	The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL Leukemia ·Afsar Mian, 유영자, Zihan Zhao, 悟小西, 美恵子河原, Tim Beißert, Oliver G. Ottmann, Martin Ruthardt	2009	38
13	Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL International Journal of Cancer ·Tim Beißert, 美恵子河原, Basanangouda Laxmeshwar, Lorena Travaglini, Afsar Mian, Clara Nervi, Martin Ruthardt	2008	34
14	Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RAR -positive leukemic stem cells Haematologica ·Xiao Zheng, Kayleigh Beard-Blackband, Brigitte Rüster, Gesine Bug, Tim Beißert, Elena Puccetti, D. Hoelzer, Reinhard Henschler, Martin Ruthardt	2007	61
15	BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility BMC Cancer ·Xiaomin Zheng, V Armella de Aspe, Tim Beißert, Elena Puccetti, Martin Ruthardt	2006	11
16	Valproic Acid Stimulates Proliferation and Self-renewal of Hematopoietic Stem Cells Cancer Research ·Gesine Bug, Dujuan Shi, K. Schwarz, Roman Pfeifer, Manuela Kampfmann, Xiaomin Zheng, Tim Beißert, Simone Boehrer, Dieter Hoelzer, Oliver G. Ottmann, Martin Ruthardt	2005	162
17	The Acute Promyelocytic Leukemia-Associated Fusion Protein PML/RAR Blocks t-RA-Induced Differentiation in a Subset of Cells with Stem Cell Potential. Blood ·Xiaomin Zheng, Kayleigh Beard-Blackband, Elena Puccetti, Dujuan Shi, Tim Beißert, Dieter Hoelzer, Oliver G. Ottmann, Reinhard Henschler, Martin Ruthardt	2004	1
18	Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis Oncogene ·Elena Puccetti, Tim Beißert, V Armella de Aspe, Hunasanahalli Giriyappa Venugopal, Dieter Hoelzer, Oliver G. Ottmann, Martin Ruthardt	2003	16
19	AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor. PubMed ·Elena Puccetti, Indra Manrique Rissech, Tim Beißert, Andrea Bianchini, Susana B. Ribotta de Gallo, Ferdinando Chiaradonna, Simone Boehrer, Dieter Hoelzer, Oliver G. Ottmann, Pier Giuseppe Pelicci, Clara Nervi, Martin Ruthardt	2002	36
20	NEGATIVE REGULATION OF IL-1β PRODUCTION AT THE LEVEL OF TRANSCRIPTION IN MACROPHAGES STIMULATED WITH LPS Cytokine ·Glenn Grenier, Tim Beißert, Matthew J. Fenton, Kathryn Nixdorff	2001	8

About Tim Beißert

Tim Beißert is a scholar working on Hematology, Genetics, Genetics, Molecular Biology and Infectious Diseases, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Retinoids in leukemia and cellular processes (5 papers), Protein Degradation and Inhibitors (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Hematology (240 citations), Infectious Diseases (355 citations), Immunology (349 citations), Molecular Biology (1.1k citations) and Animal Science and Zoology (108 citations). Tim Beißert has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Uğur Şahin, Mario Perković, Özlem Türeci, Stephanie Erbar, Martin Ruthardt, Annette B. Vogel, Oliver G. Ottmann, Heinrich Haas, Lena Wicke and Ekaterina Kinnear. Their work appears in journals such as Molecular Therapy, Human Gene Therapy, Molecular Therapy — Nucleic Acids, Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact